Back to results

AUTENTICA Launches in the UK

Share

Fox Pharma and MedFx confirmed as exclusive UK distributors for Regenyal Laboratories' physiological hyaluronic acid treatment.

AUTENTICA, an Italian-developed hyaluronic acid (HA) skin restructurer manufactured by Regenyal Laboratories, launches in the UK with Fox Pharma and MedFx confirmed as exclusive UK distributors.

Powered by 64mg of ultra-pure hyaluronic acid, AUTENTICA combines high-performance skin hydration with the Anti-Gravity Technique™ - an innovative injection approach that precisely places the product within the superficial adipose layer to create natural lift and improved skin quality with a unique bio-restructuring effect.

Dr Hasaneen Al Janabi, founder of Dr Hass Clinic and lead UK KOL comments: “For me, AUTENTICA represents an exciting and innovative movement within aesthetics because it sits somewhere between improving skin quality and creating a subtle structural effect. It isn't simply about adding hydration but rather enhancing the skin in a precise way through the Anti-Gravity Technique™. This allows for a much more considered approach to product placement, with the aim of supporting the skin's natural structure and creating a subtle lifting effect.”

Designed for advanced skin bio-restructuring, hydration and dermal quality improvement, AUTENTICA has a distinct injection protocol and mechanism of action that UK practitioners will be trained to use from launch. The trademarked Anti-Gravity Technique™ places the product within the superficial adipose layer, deeper than a standard skin booster protocol, to create a natural lifting effect alongside improved skin quality. The treatment can be administered by needle or cannula, with the protocol tailored by patient age and repeat treatment intervals of three to six months depending on individual need.

Powered by Regenyal's proprietary PHYSIOLOGIC TECH, AUTENTICA combines high molecular weight HA (800–1200kDa) with a controlled production process to create a stable structure without chemical cross-linkers or BDDE. Each syringe contains 64mg of ultra-pure HA, designed to support hydration, firmness and tissue vitality without adding visible volume. In an internal clinical study, 100% of patients rated skin texture as improved and 77% gave skin tone the highest rating following two treatments, alongside an 18% increase in skin thickness and a 1mm increase in adipose tissue thickness recorded after the first session.

“Regenyal has spent close to two decades refining the hyaluronic acid technology behind this launch. Bringing it to the UK means clinics will receive the product and the training together, which is the best possible way to introduce an innovative technique-led treatment like this,” comments John Thompson, Managing Director of Fox Pharma.

AUTENTICA is available through Fox Pharma, the brand's exclusive UK distributor and MedFx, an official pharmacy partner for AUTENTICA in the UK.

AUTENTICA practitioner training courses are live from October onwards, alongside a dedicated introductory event at King Street Townhouse for clinics and prospective training partners on 10th November 2026 – for more information contact [email protected]